Mass kidney screening in brazil reveals hidden disease burden

NCT ID NCT07103629

Completed Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study screened over 8,400 Brazilian adults with known risk factors for chronic kidney disease (CKD) using a portable creatinine test. Participants were randomly selected from five regions. Those with abnormal results were referred for lab confirmation and follow-up care. The goal was to estimate how many people have undiagnosed CKD in Brazil.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help identify how common undiagnosed chronic kidney disease is in Brazil, guiding future screening programs.
What could go wrong: This is an observational study, not a treatment trial. It only estimates prevalence and does not test any intervention or cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL INSUFFICIENCY, CHRONIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RENAL INSUFFICIENCY, CHRONIC

Contacts and locations

Show contact details

Locations

Sociedade Brasileira de Nefrologia

São Paulo, 04044-000, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.